The global mouth ulcers drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). There are several pivotal factors that are driving the market growth including high tobacco consumption and the increasing unhealthy dietary habits across the globe. Tobacco consumption is quite high as globally around 1.3 billion people were consuming tobacco in 2020 according to the World Health Organization. Moreover, there are studies that indicate that quitting smoking has a few side effects, one among which is the occurrence of mouth ulcers and cold symptoms for up to two weeks. Therefore, along with the high population base of smokers, if more people will quit smoking, there are chances of occurrence of mouth ulcers as a temporary side effect. To treat this, people will opt for various remedies including mouth ulcers drugs which will augment the global mouth ulcer drugs market. 

Moreover, the easy availability of these drugs as over-the-counter (OTC) medicines is further likely to provide a major boost to the overall market growth. Among the range of drug classes available for mouth ulcer treatment, the antimicrobial drug class, as well as analgesic drug class, are the prominent categories that support the market growth. Hence, the companies are continuously launching new innovative products, with new marketing strategies to gain the available market share. For instance, in May 2020, US WorldMeds, LLC launched GELX ORAL GEL, a Zinc-Taurine bioactive barrier therapy for the treatment of oral pain associated with Oral Mucositis (OM).

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Drug Class
• By Application

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  GlaxoSmithKline plc, and Celgene Corp., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Mouth Ulcers Drugs Market Report by Segment

By Drug Class

• Antimicrobial
• Antihistamine
• Analgesics
• Corticosteroids
• Others

By Application

• Oral Lichen Planus 
• Aphthous Stomatitis 
• Others

Global Mouth Ulcers Drugs Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa